Published in Int J Oncol on April 30, 2012
Apoptosis and G2/M arrest induced by Allium ursinum (ramson) watery extract in an AGS gastric cancer cell line. Onco Targets Ther (2013) 0.77
Overexpression of miR-199a-5p decreases esophageal cancer cell proliferation through repression of mitogen-activated protein kinase kinase kinase-11 (MAP3K11). Oncotarget (2016) 0.77
In vitro evaluation of novel N-acetylalaninate prodrugs that selectively induce apoptosis in prostate cancer cells. BMC Cancer (2014) 0.76
Endothelial nitric oxide synthase deficiency influences normal cell cycle progression and apoptosis in trabecular meshwork cells. Int J Ophthalmol (2016) 0.75
Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst (2002) 4.97
Ways of dying: multiple pathways to apoptosis. Genes Dev (2003) 4.14
A decade of caspases. Oncogene (2003) 3.55
Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: a proof of concept endoscopic study. Gastroenterology (2003) 3.21
Superoxide is the major reactive oxygen species regulating autophagy. Cell Death Differ (2009) 2.76
Aspirin-like molecules that covalently inactivate cyclooxygenase-2. Science (1998) 2.03
Epidemiology of non-steroidal anti-inflammatory drugs and cancer. Prog Exp Tumor Res (2003) 1.98
The cell cycle is a redox cycle: linking phase-specific targets to cell fate. Free Radic Biol Med (2009) 1.75
A redox cycle within the cell cycle: ring in the old with the new. Oncogene (2006) 1.63
Redox regulation of the G1 to S phase transition in the mouse embryo fibroblast cell cycle. Cancer Res (2003) 1.62
Nitric oxide-donating aspirin induces apoptosis in human colon cancer cells through induction of oxidative stress. Proc Natl Acad Sci U S A (2005) 1.51
Catalytic and chemical competence of regulation of cdc25 phosphatase by oxidation/reduction. Biochemistry (2003) 1.38
NO-donating aspirin inhibits intestinal carcinogenesis in Min (APC(Min/+)) mice. Biochem Biophys Res Commun (2004) 1.28
p53: guardian of ploidy. Mol Oncol (2011) 1.25
Positional isomerism markedly affects the growth inhibition of colon cancer cells by nitric oxide-donating aspirin in vitro and in vivo. J Pharmacol Exp Ther (2004) 1.22
Caspases: an ancient cellular sword of Damocles. Cell Death Differ (2004) 1.16
Nitric oxide-donating aspirin prevents pancreatic cancer in a hamster tumor model. Cancer Res (2006) 1.15
Oxidative stress mediates through apoptosis the anticancer effect of phospho-nonsteroidal anti-inflammatory drugs: implications for the role of oxidative stress in the action of anticancer agents. J Pharmacol Exp Ther (2011) 1.14
Effect of glutathione depletion on antitumor drug toxicity (apoptosis and necrosis) in U-937 human promonocytic cells. The role of intracellular oxidation. J Biol Chem (2001) 1.13
Nitric-oxide-donating NSAIDs as agents for cancer prevention. Trends Mol Med (2004) 1.13
Cyclooxygenase-independent chemoprevention with an aspirin derivative in a rat model of colonic adenocarcinoma. Life Sci (1998) 1.11
The genetics of cell death: approaches, insights and opportunities in Drosophila. Nat Rev Genet (2004) 1.09
Non-steroidal anti-inflammatory drugs inhibit cellular proliferation and upregulate cyclooxygenase-2 protein expression in endometrial cancer cells. Cancer Sci (2004) 1.03
Effect of H(2)O(2) on cell cycle and survival in DNA mismatch repair-deficient and -proficient cell lines. Cancer Lett (2003) 0.94
The role of NSAIDs in the prevention of colon cancer. Cancer Invest (2002) 0.91
Vitamin C transiently arrests cancer cell cycle progression in S phase and G2/M boundary by modulating the kinetics of activation and the subcellular localization of Cdc25C phosphatase. J Cell Physiol (2005) 0.81
Antitumor imidazolyl disulfide IV-2 causes irreversible G(2)/M cell cycle arrest without hyperphosphorylation of cyclin-dependent kinase Cdk1. J Pharmacol Exp Ther (2000) 0.81
Nitric oxide-donating nonsteroidal anti-inflammatory drugs inhibit the growth of various cultured human cancer cells: evidence of a tissue type-independent effect. J Pharmacol Exp Ther (2002) 1.41
Positional isomerism markedly affects the growth inhibition of colon cancer cells by nitric oxide-donating aspirin in vitro and in vivo. J Pharmacol Exp Ther (2004) 1.22
NO-donating NSAIDs and cancer: an overview with a note on whether NO is required for their action. Nitric Oxide (2008) 1.16
Nitric oxide-donating aspirin prevents pancreatic cancer in a hamster tumor model. Cancer Res (2006) 1.15
NO-donating nonsteroidal antiinflammatory drugs (NSAIDs) inhibit colon cancer cell growth more potently than traditional NSAIDs: a general pharmacological property? Biochem Pharmacol (2004) 1.10
NO-donating aspirin isomers downregulate peroxisome proliferator-activated receptor (PPAR)delta expression in APC(min/+) mice proportionally to their tumor inhibitory effect: Implications for the role of PPARdelta in carcinogenesis. Carcinogenesis (2005) 1.06
Regulation of peroxisome proliferator-activated receptor-beta/delta by the APC/beta-CATENIN pathway and nonsteroidal antiinflammatory drugs. Mol Carcinog (2009) 0.98
Functional characterization of peroxisome proliferator-activated receptor-β/δ expression in colon cancer. Mol Carcinog (2011) 0.93
NO-releasing NSAIDs and colon cancer chemoprevention: a promising novel approach (Review). Int J Oncol (2002) 0.84
NO-donating aspirin inhibits angiogenesis by suppressing VEGF expression in HT-29 human colon cancer mouse xenografts. Carcinogenesis (2008) 0.80
A novel NSAID derivative, phospho-ibuprofen, prevents AOM-induced colon cancer in rats. Int J Oncol (2012) 0.76
Correction: Aberrant DNA Methylation: Implications in Racial Health Disparity. PLoS One (2016) 0.75
Preliminary anti-cancer photodynamic therapeutic in vitro studies with mixed-metal binuclear ruthenium(II)-vanadium(IV) complexes. Dalton Trans (2013) 0.75